IVOCLAR VIVADENT supplier risk profile Q1-2026: 188 shipments, 4 suppliers, compliance assessment.
IVOCLAR VIVADENT imported 188 shipments in Q1 2026 across 4 suppliers and 3 countries, with 95.2% of volume originating from an unspecified country. The importer sources primarily from IVOCLAR VIVADENT entities, along with W H DENTALWERK BURMOOS (Austria). Medicinal and pharmaceutical products (HS Chapter 30) dominate the import mix, followed by optical and medical instruments (HS Chapter 90).
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
No sanctions watchlist matches were detected for this importer in Q1 2026. No suppliers register exposure to forced-labor sourcing risk under UFLPA criteria.
4 distinct tier-1 suppliers in Q1 2026
| IVOCLAR VIVADENT | - | 179 |
| IVOCLAR VIVADENT | United States | 6 |
| W H DENTALWERK BURMOOS | Austria | 2 |
| IVOCLAR VIVADENT | Austria | 1 |
Share of Q1 2026 inbound shipments by source country
3 tier-2 + 4 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.